[1]刘玲慧,袁 滢,潘 玉,等.穴位埋线联合丹莪妇康煎膏治疗子宫内膜异位症痛经疗效及对患者血清CA125的影响[J].陕西中医,2025,46(1):122-125.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.027]
　LIU Linghui,YUAN Ying,PAN Yu,et al.Clinical efficacy and effect on serum CA125 of acupoint catgut embedding combined with Dan'e Fukang decoction in the treatment of endometriosis dysmenorrhea[J].,2025,46(1):122-125.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.027]
点击复制

穴位埋线联合丹莪妇康煎膏治疗子宫内膜异位症痛经疗效及对患者血清CA125的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年1期
页码:
122-125
栏目:
针灸经络
出版日期:
2025-01-05

文章信息/Info

Title:
Clinical efficacy and effect on serum CA125 of acupoint catgut embedding combined with Dan'e Fukang decoction in the treatment of endometriosis dysmenorrhea
作者:
刘玲慧1; 袁 滢1; 潘 玉1; 张 婕1; 丁天增1; 张天婵2
(1.黑龙江中医药大学,黑龙江 哈尔滨 150040; 2.黑龙江中医药大学附属第二医院,黑龙江 哈尔滨 150001)
Author(s):
LIU Linghui; YUAN Ying; PAN Yu; ZHANG Jie; DING Tianzeng; ZHANG Tianchan
(Heilongjiang University of Chinese Medicine,Harbin 150040,China)
关键词:
子宫内膜异位症;  痛经;  穴位埋线;  丹莪妇康煎膏;  气滞血瘀型;  血清糖类抗原125
Keywords:
Endometriosis;  Dysmenorrhea;  Acupoint catgut embedding;  Dan'e Fukang decoction;  Qi stagnation and blood stasis;  Serum carbohydrate antigen 125
分类号:
R 711.71
DOI:
DOI:10.3969/j.issn.1000-7369.2025.01.027
文献标志码:
A
摘要:
目的:探究采用穴位埋线联合丹莪妇康煎膏疗法对子宫内膜异位症(EMs)痛经患者(气滞血瘀型)的临床治疗效果及其对血清糖类抗原125(CA125)的影响。方法:将66例EMs痛经患者(气滞血瘀型)随机分为两组,各33例。对照组给予丹莪妇康煎膏治疗,观察组在此基础上辅以穴位埋线疗法,两组均连续治疗3个月经周期。记录两组患者的临床疗效和不良反应; 比较治疗前、治疗3个月经周期后经期视觉模拟评分量表(VAS)评分、痛经症状评分、气滞血瘀型痛经的中医证候积分及血清CA125水平变化。结果:观察组总有效率96.77%高于对照组86.67%(P<0.05); 治疗3个月经周期后,两组的经期VAS评分、痛经症状评分、气滞血瘀型痛经中医证候积分及血清CA125水平均较治疗前降低,且在上述指标的改善幅度方面,观察组均显著优于对照组(均P<0.05); 两组不良反应率比较差异无统计学意义(P>0.05)。结论:穴位埋线联合丹莪妇康煎膏可有效缓解气滞血瘀型EMs痛经及其伴随症状,改善中医证候,且能降低血清CA125水平、抑制异位内膜进展,提高临床疗效。
Abstract:
Objective:To observe the clinical efficacy and effect on serum carbohydrate antigen 125(CA125)of acupoint catgut combined with Dan'e Fukang decoction in the treatment of dysmenorrhoea in endometriosis(EMs)of the qi stagnation and blood stasis type.Methods:66 patients were randomly divided into two groups of 33 each with dysmenorrhea in qi stagnation and blood stasis EMs.The control group was treated orally with Dan'e Fukang decoction,and the observation group was supplemented with acupoint catgut on this basis,and both groups were treated for 3 consecutive menstrual cycles.The clinical efficacy of the two groups was compared.The visual analogue scale(VAS)scores,dysmenorrhoea scores,Chinese medicine symptom scores and serum CA125 levels were compared before and after the treatment,and the adverse reactions during the treatment period were observed and recorded.Results:Follwing treatment,treatment efficacy was higher in the observed group than those in the control group(P<0.05).The menstrual VAS score,dysmenorrhoea symptom score,Chinese medicine symptom score and serum CA125 level of the patients in both groups were reduced compared with the pre-treatment period,and the increase in attractiveness indices of the observation group was better than those in the control group(all P<0.05).Side effect rates had no statistically significant(P>0.05).Conclusion:Acupoint catgut embedding combined with Dan'e Fukang decoction can effectively relieve dysmenorrhoea and its accompanying symptoms in EMs with qi stagnation and blood stasis,improve the Chinese medicine evidence,and can reduce serum CA125 level,inhibit the progress of ectopic endothelium,and improve the clinical efficacy.

参考文献/References:

[1] 中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症诊治指南(第三版)[J].中华妇产科杂志,2021,56(12):812-824.
[2] 子宫内膜异位症疼痛管理指南(2024年实践版)[J].中国实用妇科与产科杂志,2024,40(1):50-61.
[3] AHN S H,MONSANTO S P,MILLER C,et al.Pathophysiology and immune dysfunction in endometriosis[J].BioMed Research International,2015,2015(1):795976.
[4] 朱小琳,胡晓萌,杨东霞,等.内异止痛方联合中药直肠滴入治疗气滞血瘀型子宫内膜异位症痛经的临床观察[J].辽宁中医杂志,2023,50(11):77-80.
[5] 中国中西医结合学会妇产科专业委员会.子宫内膜异位症中西医结合诊治指南[J].中国中西医结合杂志,2019,39(10):1169-1176.
[6] 李亚欣,傅金英,李东东,等.基于“不通则痛”探讨中医药治疗子宫内膜异位症痛经机制的研究进展[J].世界中医药,2024,19(17):2696-2703.
[7] 陈景伟,刘慧敏,马艺鸣.子宫内膜异位症相关疼痛中医诊疗指南[J].中华中医药学刊,2024,42(5):250-258.
[8] DUNSELMAN G A J,VERMEULEN N,BECKER C,et al.ESHRE guideline:Management of women with endometriosis[J].Human Reproduction,2014,29(3):400-412.
[9] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:15-19.
[10] 张平芳.从心肝论治气滞血瘀型子宫内膜异位症痛经的临床观察[D].兰州:甘肃中医药大学,2021.
[11] 赵佳琪,刘凯莉,李昱帅,等.子宫内膜异位症相关通路及中医药干预研究进展[J].陕西中医,2023,44(9):1316-1319.
[12] 张妙玉,高间容.穴位埋线联合理冲汤加减治疗子宫内膜异位症疗效观察[J].陕西中医,2017,38(9):1210-1211.
[13] 林素芬.子宫内膜异位症近20年中医临床文献研究[D].广州:广州中医药大学,2013.
[14] 苗振立,李伟.桃红内异散对大鼠子宫内膜异位病灶microRNA-126的影响[J].光明中医,2019,34(23):3572-3574.
[15] 李新,史玉霞,谢秋容.丹莪妇康煎膏用于人工流产术后的临床观察[J].中国实用妇科与产科杂志,2007(6):493.
[16] 张欣颖,魏嘉茵,潘婕,等.丹莪妇康煎膏治疗子宫内膜异位症的Meta分析[J].药物评价研究,2024,47(1):160-170.
[17] 白俊嫄.穴位埋线周期序贯疗法治疗气滞血瘀型原发性痛经的临床研究[D].兰州:甘肃中医药大学,2019.
[18] 丛慧芳,谷栩萌,张天婵,等.穴位埋线对子宫内膜异位症性痛经的临床研究[J].针灸临床杂志,2018,34(3):43-46.
[19] 刘英含,钟峰,石文英,等.子宫穴在妇科疾病中的应用及现代理论依据[J].上海针灸杂志,2015,34(4):364-366.
[20] 陈广贤.穴位埋线疗法治疗子宫内膜异位症痛经疗效观察研究[D].广州:广州中医药大学,2015.
[21] 曹慧,贺小林,张状金.化瘀消异定痛汤联合穴位埋线治疗子宫内膜异位症30例[J].湖南中医杂志,2021,37(10):8-11.
[22] 何贤.辞异饮治疗气滞血瘀型子宫内膜异位症的临床研究[D].福州:福建中医药大学,2018.
[23] 王静,张虹宇,张磊,等.动脉灌注化疗联合细胞因子诱导杀伤细胞治疗晚期卵巢癌疗效及对患者血清癌胚抗原、糖类抗原125、可溶性B7-H4蛋白水平的影响[J].陕西医学杂志,2024,53(2):199-202,206.
[24] 张莉,金晶,季菲.丹莪妇康煎膏联合孕三烯酮治疗子宫内膜异位症疗效及对患者CA125、TNF-α和IL-6水平的影响[J].陕西中医,2020,41(10):1370-1372.
[25] 马艳华,顾晓丁.穴位埋线结合艾灸治疗原发性痛经患者对子宫动脉血流动力学和VAS评分的影响[J].针灸临床杂志,2022,38(3):21-25.

相似文献/References:

[1]胡贞君,刘笑梅△,曹保利.复方莪术散治疗子宫内膜异位症疗效及其分子学研究进展*[J].陕西中医,2019,(9):1315.
[2]张 莉,金 晶,季 菲△.丹莪妇康煎膏联合孕三烯酮治疗子宫内膜异位症疗效及对患者CA125、TNF-α和IL-6水平的影响*[J].陕西中医,2020,(10):1370.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.007]
[3]李承秋,吕文艺,金 凡,等.活血消异汤联合米非司酮对子宫内膜异位症患者血清MMP-3、CA125、EMAb水平的影响[J].陕西中医,2021,(3):297.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.006]
　LI Chengqiu,LV Wenyi,JIN Fan,et al.Effect of Huoxue Xiaoyi decoction combined with mifepristone on the serum levels of MMP-3,CA125 and EMAb in patients with endometriosis[J].,2021,(1):297.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.006]
[4]陈亚杰,闻 姬.子宫内膜异位症中西医认识及治疗研究进展[J].陕西中医,2021,(10):1486.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.043]
[5]余 震,柳 洲.消瘤方对子宫内膜异位症大鼠盆腔粘连的影响[J].陕西中医,2022,(1):13.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.003]
　YU Zhen,LIU Zhou.Effect and the mechanism of Xiaoliu decoction on pelvic adhesion in rats with endometriosis[J].,2022,(1):13.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.003]
[6]董秀娟,曹若愚,于洪基,等.大蒜素对子宫内膜异位症大鼠异位病灶及缺氧诱导因子-1α表达的影响[J].陕西中医,2022,(4):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
　DONG Xiujuan,CAO Ruoyu,YU Hongji,et al.Effects of Allicin on the ectopic lesions and the expression of HIF-1α in rats with endometriosis[J].,2022,(1):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
[7]赵 娜,周灵雪,杨向荣.桂枝茯苓胶囊联合戈舍瑞林对子宫内膜异位症患者子宫动脉血流动力学及Th1/Th2细胞因子的影响[J].陕西中医,2022,(4):446.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.008]
　ZHAO Na,ZHOU Lingxue,YANG Xiangrong.Effects of Guizhi Fuling capsule combined with goserelin on uterine artery hemodynamics and Th1/Th2 cytokines in endometriosis patients[J].,2022,(1):446.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.008]
[8]刘 叶,赵亚芹.活血通络解毒汤治疗子宫内膜异位症疗效及对患者卵巢功能的影响[J].陕西中医,2022,(4):450.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.009]
　LIU Ye,ZHAO Yaqin.Therapeutic effect of Huoxue Tongluo Jiedu decoction on endometriosis and its influence on ovarian function of patients[J].,2022,(1):450.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.009]
[9]杨润雨,陈 瑶,冯晓玲.中医药治疗子宫内膜异位症致不孕研究进展[J].陕西中医,2023,(5):670.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.032]
　YANG Runyu,CHEN Yao,FENG Xiaoling.Research progress of traditional Chinese medicine in the treatment of infertility caused by endometriosis[J].,2023,(1):670.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.032]
[10]赵佳琪,刘凯莉,李昱帅,等.子宫内膜异位症相关通路及中医药干预研究进展[J].陕西中医,2023,(9):1316.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.038]
　ZHAO Jiaqi,LIU Kaili,LI Yushuai,et al.Research progress on the related pathways of endometriosis and the intervention of traditional Chinese medicine[J].,2023,(1):1316.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.038]
[11]宋梦杨,连 方.连方教授治疗子宫内膜异位症经验[J].陕西中医,2022,(4):511.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.026]
　SONG Mengyang,LIAN Fang.LIAN Fang's experience in treating endometriosis with Quyu Jiedu decoction[J].,2022,(1):511.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.026]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81704113); 黑龙江中医药大学研究生创新科研项目(2024YJSCX034)
更新日期/Last Update: 2025-01-09